fda
Bipartisan Legislation Introduced Would Create Regulatory Pathways for Use of Hemp-derived CBD in Dietary Supplements and Conventional Food
On May 19, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace. The Hemp Access and Consumer Safety Act of 2021 would amend the Federal Food, Drug and Cosmetic Act (FD&CA) ...
NAI Becomes First Company to Meet New SSCI Benchmarking Standards
Natural Alternatives International (NAI, Carlsbad, CA) has become the first company to meet new safety and benchmarking standards created by the Supplement Safety & Compliance Initiative (SSCI). The announcement follows a more than five-year effort by the world’s leading nutritional supplement retailers—including Walmart and GNC—in collaboration with the Natural Products Association (NPA) and its members, to ...
100th Meeting of the Dietary Supplement Trade Associations Commemorated
On April 26, four of the leading trade organizations representing the dietary supplement industry commemorated the 100th meeting of the Dietary Supplement Trade Associations (DSTA). More than 10 years ago, the American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), and the United Natural Products Alliance (UNPA) began ...
FDA Warns Selling of Topical CBD Products Violates FD&C Act
On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs ...
CRN Applauds House Resolution Recognizing Vitamin D for Decreasing the Severity of COVID-19
The Council for Responsible Nutrition (CRN) said it applauds U.S. Representative Glenn Grothman (R-WI) for introducing a House Resolution (H. Res. 116) that recognizes the potential role vitamin D may play in decreasing the severity of COVID-19. The resolution calls on the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug ...
FDA Withdraws Draft Guidance on CBD Enforcement Policy
After the Biden administration released a memo on Jan. 20 to all federal agencies informing them of a “regulatory freeze pending review,” the U.S. Food and Drug Administration (FDA) withdrew its “Cannabidiol Enforcement Policy; Draft Guidance for Industry.” Before it was withdrawn, the guidance was at the Office of Management and Budget (OMB) awaiting review. In ...
New Hampshire Becomes Latest State to Propose CBD Regs to Fill FDA Vacuum
As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum. New Hampshire recently became the latest state to propose new state regulations for consumable hemp and CBD products. Kyle Turk, director for government affairs, ...
CRN: New FDA Announcement on CBD Signals Continued Agency Inaction
In response to a notice issued on Jan. 8, 2021, from the U.S. Food and Drug Administration (FDA), titled, “Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products,” the Council for Responsible Nutrition (CRN) issued the following statement: “Today’s notice, late in the day, late in a week that ...
CRN Announces New, Upgraded Supplement OWL Platform
The Council for Responsible Nutrition (CRN) has announced upgrades to the Supplement OWL (Online Wellness Library), the dietary supplement industry’s self-regulatory product listing. Companies looking to participate in the Supplement OWL now have additional support options to upload their dietary supplement product information into this important industry initiative. “Serving as a resource for regulators, retailers, industry and consumers since ...
CHPA Responds to AMA Policy Calling For Increased Regulation of Dietary Supplements
At the Special Meeting of the American Medical Association (AMA) House of Delegates, physicians adopted new policy, which expands upon the AMA’s existing policy to call for more stringent federal regulation of dietary supplements—including increased oversight of manufacturing, marketing, product labeling and adverse event reporting. Under the new policy, the AMA strongly urges Congress to ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
